OMIC: Gunggunge utang jangka dawa Singular Genomics Systems, Inc.

Lambang korporat lan logo Singular Genomics Corp (OMIC)

Singular Genomics Systems (OMIC) generates revenue from the supply of sequencing systems, utilizing a recurring sales model for components to maintain high FCF. Business process efficiency is achieved by outsourcing electronics assembly and logistics to third-party contractors. The price action chart provided below reflects the trend amid growing demand from biotech laboratories. The current debt load is 0.05.

OMIC (Singular Genomics Systems, Inc.) riwayat Utang jangka dawa perusahaan saka 04.07.2022 nganti 01.03.2025
Produk seri Singular Genomics Systems Inc

This indicator captures the total volume of credit obligations for Singular Genomics Systems (OMIC) with maturities exceeding twelve months. The metric assesses the long-term debt load and the stability of the company's liability structure. By analyzing changes in the issuer's long-term liabilities, investors can determine the default risk in the event of declining liquidity. An increase in borrowings may signal a search for resources to fund expansion. Amid geopolitical fragmentation of the sequencing market, such debts become critical when export flows are restricted.

Karo sapa Singular Genomics Systems saingan

Tempus Labs - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan QGEN (Qiagen)|IONS - Gunggunge utang jangka dawa|Repligen Corp. - Utang jangka dawa perusahaan|RNA (Avidity Corp) - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan CRISPR Therapeutics AG (CRSP)|Tanggungan utang jangka dawa perusahaan genedx.com|RARE: Utang jangka dawa perusahaan|Tanggungan jangka dawa Beam Therapeutics Inc BEAM|Kewajiban jangka dawa perusahaan SRPT (Sarepta Therapeutics Inc)|Twist Bioscience Corp - Utang jangka dawa perusahaan|TXG - Utang jangka dawa perusahaan|NTLA - Utang jangka dawa perusahaan|STOK: Utang jangka dawa perusahaan|BLFS (BioLife Solutions Inc) - Utang jangka dawa perusahaan|WVE - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan Maze Therapeutics Corp (MAZE)|Sionna Therapeutics Inc (SION) - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan primemedicine.com (PRME)|TSHA (Taysha Gene Therapies, Inc.) - Utang jangka dawa perusahaan|Tanggungan jangka dawa uniQure NV QURE|MGTX (MeiraGTx PLC) - Utang jangka dawa perusahaan|RGNX: Utang jangka dawa|Utang jangka dawa perusahaan Solid Biosciences Inc.|OCGN (ocugen.com) - Tanggungan utang jangka dawa perusahaan|Utang jangka dawa perusahaan PACB (PacBio)|Utang jangka dawa BNTC|Utang jangka dawa perusahaan DSGN (Design Pharma)|Kewajiban jangka dawa perusahaan Rocket Corp (RCKT)|Utang jangka dawa perusahaan FDMT|Gunggunge utang jangka dawa Lexeo Therapeutics Inc. LXEO|KRRO: Utang jangka dawa perusahaan|EDIT: Kewajiban jangka dawa perusahaan|Silence Therapeutics Inc. - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa ProQR Therapeutics|CDXS - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan SGMO|NAUT (Nautilus Biotechnology) - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa Metagenomi Inc. MGX|DTIL: Kewajiban jangka dawa perusahaan|Generation Bio Co - Utang jangka dawa|Utang jangka dawa perusahaan BOLD (Boundless Bio, Inc.)|Exicure, Inc. (XCUR) - Gunggunge utang jangka dawa|IMNN - Kewajiban jangka dawa perusahaan|Phio Pharmaceuticals Corp. (PHIO) - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan MBIO (Mustang Bio Inc)|Utang jangka dawa RNAZ|Utang jangka dawa perusahaan BNGO (Bionano Genomics, Inc.)|Kewajiban jangka dawa perusahaan APDN (adnas.com)|Utang jangka dawa perusahaan BLUE|ImmunoPrecise Antibodies Ltd - Gunggunge utang jangka dawa|OMGA (Omega) - Utang jangka dawa perusahaan|RGLS: Utang jangka dawa|SYRS (Syros Pharmaceuticals) - Utang jangka dawa perusahaan|telesisbio.com (TBIO) - Kewajiban jangka dawa perusahaan|TCON: Utang jangka dawa perusahaan|Gunggunge utang jangka dawa Unity Biotechnology Inc.